ATE22928T1 - Verfahren zur bestimmung der wirksamkeit von plasminogen-aktivator des gewebes und zur verwendung in diesem verfahren geeigneter reagenzsatz. - Google Patents
Verfahren zur bestimmung der wirksamkeit von plasminogen-aktivator des gewebes und zur verwendung in diesem verfahren geeigneter reagenzsatz.Info
- Publication number
- ATE22928T1 ATE22928T1 AT83200670T AT83200670T ATE22928T1 AT E22928 T1 ATE22928 T1 AT E22928T1 AT 83200670 T AT83200670 T AT 83200670T AT 83200670 T AT83200670 T AT 83200670T AT E22928 T1 ATE22928 T1 AT E22928T1
- Authority
- AT
- Austria
- Prior art keywords
- procedure
- plasmin
- fibrinogen
- fibrin
- plasminogen activator
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
- C12Q2337/10—Anilides
- C12Q2337/12—Para-Nitroanilides p-NA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/968—Plasmin, i.e. fibrinolysin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9726—Tissue plasminogen activator
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8201987A NL8201987A (nl) | 1982-05-13 | 1982-05-13 | Werkwijze voor het bepalen van de activiteit van plasminogeenactivator van het weefseltype, alsmede voor gebruik bij deze werkwijze geschikte combinatie van het "kit"-type. |
EP83200670A EP0094720B1 (de) | 1982-05-13 | 1983-05-09 | Verfahren zur Bestimmung der Wirksamkeit von Plasminogen-Aktivator des Gewebes und zur Verwendung in diesem Verfahren geeigneter Reagenzsatz |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE22928T1 true ATE22928T1 (de) | 1986-11-15 |
Family
ID=19839733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT83200670T ATE22928T1 (de) | 1982-05-13 | 1983-05-09 | Verfahren zur bestimmung der wirksamkeit von plasminogen-aktivator des gewebes und zur verwendung in diesem verfahren geeigneter reagenzsatz. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4563420A (de) |
EP (1) | EP0094720B1 (de) |
JP (1) | JPS58209999A (de) |
AT (1) | ATE22928T1 (de) |
DE (1) | DE3366963D1 (de) |
NL (1) | NL8201987A (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1254119A (en) * | 1984-07-20 | 1989-05-16 | Lloyd A. Schick | Single step protease inhibitor assay |
DE3430906A1 (de) * | 1984-08-22 | 1986-02-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung von fibrinmonomer in plasma |
US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
DE3512909A1 (de) * | 1985-04-11 | 1986-10-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur bestimmung von plasminogenaktivatoren (pa) |
US5096811A (en) * | 1986-03-12 | 1992-03-17 | Genentech, Inc. | Novel assay system for measuring human plasminogen actuator activity |
AT388618B (de) * | 1987-05-05 | 1989-08-10 | Binder Bernd Dr | Verfahren zur quantitativen bestimmung von funktion und antigener konzentration einer in einer biologischen fluessigkeit enthaltenen substanz |
SE8702556D0 (sv) * | 1987-06-18 | 1987-06-18 | Kabivitrum Ab | Bestemning av vid proteolys aktiva komponenter |
US5312745A (en) * | 1987-06-18 | 1994-05-17 | Chromogenix Ab | Determination of components active in proteolysis |
JP2520424B2 (ja) * | 1987-07-03 | 1996-07-31 | 帝人株式会社 | 血液線溶活性の測定方法 |
EP0576039A3 (en) * | 1987-07-06 | 1994-06-08 | Biopool Int Inc | Method of determining tissue plasminogen activator activity in biological fluids |
US5114845A (en) * | 1987-07-06 | 1992-05-19 | Biopool International, Inc. | Assays for plasminogen activator inhibitor and soluble fibrin |
EP0576038B1 (de) * | 1987-07-06 | 1999-10-06 | Biopool International, Inc. | Verfahren zur Messung von Gewebeplasminogenaktivator, Antithrombin-III und lösliches Fibrin |
US5206140A (en) * | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
NL8802710A (nl) * | 1988-11-04 | 1990-06-01 | Tno | Werkwijze voor het bepalen van een enzym en daarvoor geschikte kit en stof. |
DE3843422A1 (de) * | 1988-12-23 | 1990-06-28 | Behringwerke Ag | Verfahren zur bestimmung der plasminogenaktivator-aktivitaet in alpha-2-antiplasmin-haltigen proben |
FI91777C (fi) * | 1990-04-02 | 1994-08-10 | Elomit Oy | Menetelmä plasmiiniaktiivisuuden määrittämiseksi |
JPH04233458A (ja) * | 1990-08-23 | 1992-08-21 | New York Blood Center Inc | 可溶性フィブリン様モノマーを使ったアッセイ |
AU4279900A (en) * | 1999-04-28 | 2000-11-10 | Cardiogenics Inc. | Method for determining plasminogen activator inhibitor |
AU2006281969B2 (en) * | 2005-08-12 | 2011-10-06 | Biopower Systems Pty. Ltd. | A mooring |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2431342C3 (de) * | 1973-07-27 | 1978-10-26 | Behringwerke Ag, 3550 Marburg | Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe |
SE407571B (sv) * | 1975-07-11 | 1979-04-02 | Kabi Ab | Nya kromogena enzymsubstrat for serinproteaser |
CH634662A5 (de) * | 1976-05-28 | 1983-02-15 | Pentapharm Ag | Verwendung von tripeptidderivaten zur quantitativen bestimmung von plasminogen-aktivatoren. |
-
1982
- 1982-05-13 NL NL8201987A patent/NL8201987A/nl not_active Application Discontinuation
-
1983
- 1983-05-06 US US06/492,494 patent/US4563420A/en not_active Expired - Lifetime
- 1983-05-09 EP EP83200670A patent/EP0094720B1/de not_active Expired
- 1983-05-09 DE DE8383200670T patent/DE3366963D1/de not_active Expired
- 1983-05-09 AT AT83200670T patent/ATE22928T1/de not_active IP Right Cessation
- 1983-05-13 JP JP58083972A patent/JPS58209999A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
EP0094720B1 (de) | 1986-10-15 |
DE3366963D1 (en) | 1986-11-20 |
US4563420A (en) | 1986-01-07 |
EP0094720A1 (de) | 1983-11-23 |
JPH0417640B2 (de) | 1992-03-26 |
NL8201987A (nl) | 1983-12-01 |
JPS58209999A (ja) | 1983-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE22928T1 (de) | Verfahren zur bestimmung der wirksamkeit von plasminogen-aktivator des gewebes und zur verwendung in diesem verfahren geeigneter reagenzsatz. | |
ATE315233T1 (de) | Verfahren zur bestimmung des antikoagulatorischen potentials einer probe und verfahren zur bestimmung der glykosilierung von thrombomodulin | |
DE69018910D1 (de) | Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren. | |
US4234682A (en) | Method and reagent for determining biologically active heparin in plasma | |
DE3585129D1 (de) | Verfahren zur ueberwachung der blutgerinnung. | |
DE69429770D1 (de) | Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays | |
EP0632270A4 (de) | Verfahren zur bestimmung der aktivität des blutgerinnungsfaktors xiii und reagentiensatz dafür. | |
DE3780485D1 (de) | Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet. | |
ATE52140T1 (de) | Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer. | |
DE69610558D1 (en) | Test für thrombosegefahr | |
ES8607243A1 (es) | Esteres de aminoacidos y de peptidos cromogenos | |
DE60037864D1 (de) | Enzymhemmungsimmunverfahren | |
Pabinger-Fasching et al. | High levels of plasma protein C in nephrotic syndrome | |
ATE40718T1 (de) | Verfahren zur bestimmung von fibrinmonomer in plasma. | |
ATE36557T1 (de) | Verfahren zur bestimmung der wirksamkeit von substraten oder enzymen. | |
DE59302119D1 (de) | Verfahren zur bestimmung von hirudin und synthetischen trhombininhibitoren | |
DE69731845D1 (de) | Verfahren zum nachweis von protein s | |
DE69026006D1 (de) | Enzymatisches Verfahren zur Bestimmung der Analyt-Konzentration | |
Walker et al. | The molecular mechanisms of heparin action: II. Separation of functionally different heparins by affinity chromatography | |
US5529905A (en) | Method of assaying plasma proteins with prothrombin fragments | |
ATE170569T1 (de) | Verfahren zur bestimmung von fibrinogen | |
DE59008621D1 (de) | Verfahren und Reagenz zur Bestimmung von Antithrombin III. | |
ATE28758T1 (de) | Verfahren und reagenz zur bestimmung von ncarbamoylsarcosin und hierfuer geeignetes neues enzym. | |
JP2000329770A (ja) | トロンビン/アンチトロンビン系の機能性を評価するための包括的試験 | |
ATE30340T1 (de) | Analytisches verfahren und mittel zur bestimmung der protease-hemmungsfaehigkeit von serum. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |